Economic burden of refractory chronic spontaneous urticaria on Kuwait’s health system

References

• ZuberbierTAseroRBindslev-JensenCDermatology Section of the European Academy of Allergology and Clinical ImmunologyGlobal Allergy and Asthma European NetworkEuropean Dermatology ForumWorld Allergy OrganizationEAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticariaAllergy200964101417142619772512
   PubMed Web of Science ®Google Scholar
• GrattanCESabroeRAGreavesMWChronic urticariaJ Am Acad Dermatol2002465645657 quiz 657–66012004303
   PubMed Web of Science ®Google Scholar
• HideMFrancisDMGrattanCEHakimiJKochanJPGreavesMWAutoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticariaN Engl J Med199332822159916047683772
   PubMed Web of Science ®Google Scholar
• AltrichterSPeterHJPisarevskajaDMetzMMartusPMaurerMIgE mediated autoallergy against thyroid peroxidase – a novel pathomechanism of chronic spontaneous urticaria?PLoS One201164e1479421532759
   PubMed Web of Science ®Google Scholar
• MaurerMAltrichterSBieberTEfficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseJ Allergy Clin Immunol20111281202209.e20521636116
   PubMed Web of Science ®Google Scholar
• SabroeRAPoonEOrchardGECutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodiesJ Allergy Clin Immunol19991033 pt 148449310069884
   PubMed Web of Science ®Google Scholar
• MaurerMWellerKBindslev-JensenCUnmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force reportAllergy201166331733021083565
   PubMed Web of Science ®Google Scholar
• KangMJKimHSKimHOParkYMThe impact of chronic idiopathic urticaria on quality of life in korean patientsAnn Dermatol200921322622920523794
   PubMed Web of Science ®Google Scholar
• ZuberbierTBalkeMWormMEdenharterGMaurerMEpidemiology of urticaria: a representative cross-sectional population surveyClin Exp Dermatol201035886987320456386
   PubMed Web of Science ®Google Scholar
• O’DonnellBFUrticaria: impact on quality of life and economic costImmunol Allergy Clin North Am20143418910424262691
   PubMed Web of Science ®Google Scholar
• EnginBUguzFYilmazEOzdemirMMevlitogluIThe levels of depression, anxiety and quality of life in patients with chronic idiopathic urticariaJ Eur Acad Dermatol Venereol2008221364018181971
   PubMed Web of Science ®Google Scholar
• ZuberbierTAbererWAseroREuropean Academy of Allergy and Clinical ImmunologyGlobal Allergy and Asthma European NetworkEuropean Dermatology ForumWorld Allergy OrganizationThe EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and updateAllergy201469786888724785199
   PubMed Web of Science ®Google Scholar
• WuKCJabbar-LopezZKOmalizumab, an Anti-IgE mAb, receives approval for the treatment of chronic idiopathic/spontaneous urticariaJ Invest Dermatol20151351131525501377
   PubMed Web of Science ®Google Scholar
• ZuberbierTMaurerMOmalizumab for the treatment of chronic urticariaExpert Rev Clin Immunol201511217118025566680
   PubMed Web of Science ®Google Scholar
• SainiSSBindslev-JensenCMaurerMEfficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled studyJ Invest Dermatol2015135392525501032
   PubMed Web of Science ®Google Scholar
• VichyanondPOmalizumab in allergic diseases, a recent reviewAsian Pac J Allergy Immunol201129320921922053590
   PubMed Web of Science ®Google Scholar
• MitchellSBalpMMSamuelMMcBrideDMaurerMSystematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatmentsInt J Dermatol20155491088110425515967
   PubMed Web of Science ®Google Scholar
• McCormackPLOmalizumab: a review of its use in patients with chronic spontaneous urticariaDrugs201474141693169925217402
   PubMed Web of Science ®Google Scholar
• KaplanAPJosephKMaykutRJGebaGPZeldinRKTreatment of chronic autoimmune urticaria with omalizumabJ Allergy Clin Immunol2008122356957318774392
   PubMed Web of Science ®Google Scholar
• ShawahnaRMasriDAl-GharabehRDeekRAl-ThaybaLHalawehMMedication administration errors from a nursing viewpoint: a formal consensus of definition and scenarios using a Delphi techniqueJ Clin Nurs2016253–441242326748442
   PubMed Web of Science ®Google Scholar
• RosengartMRNathensABSchiffMAThe identification of criteria to evaluate prehospital trauma care using the Delphi techniqueJ Trauma200762370871317414352
   PubMedGoogle Scholar
• KhadadahMThe cost of asthma in KuwaitMed Princ Pract2013221879122889866
   PubMed Web of Science ®Google Scholar
• HayRJJohnsNEWilliamsHCThe global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditionsJ Invest Dermatol201413461527153424166134
   PubMed Web of Science ®Google Scholar
• GaigPOlonaMMunoz LejarazuDEpidemiology of urticaria in SpainJ Investig Allergol Clin Immunol2004143214220
   PubMed Web of Science ®Google Scholar
• BakkePGulsvikAEideGEHay fever, eczema and urticaria in southwest Norway. Lifetime prevalences and association with sex, age, smoking habits, occupational airborne exposures and respiratory symptomsAllergy19904575155222252162
   PubMed Web of Science ®Google Scholar
• KozelMMMekkesJRBossuytPMBosJDNatural course of physical and chronic urticaria and angioedema in 220 patientsJ Am Acad Dermatol200145338739111511835
   PubMed Web of Science ®Google Scholar
• DelongLKCullerSDSainiSSBeckLAChenSCAnnual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patientsArch Dermatol20081441353918209166
   PubMedGoogle Scholar
• FariaRMcKennaCPalmerSOptimizing the position and use of omalizumab for severe persistent allergic asthma using cost-effectiveness analysisValue Health201417877278225498772
   PubMed Web of Science ®Google Scholar
• NormanGFariaRPatonFOmalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluationHealth Technol Assess20131752134224267198
   PubMed Web of Science ®Google Scholar
• Dal NegroRWPradelliLTognellaSMichelettoCIannazzoSCost-utility of add-on omalizumab in difficult-to-treat allergic asthma in ItalyEur Ann Allergy Clin Immunol2011432455321608372
   PubMedGoogle Scholar